Hasil Pencarian - Trevor Smart

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    P666: The accuracy of variant-specific literature search results using LitVar2

    P666: The accuracy of variant-specific literature search results using LitVar2 oleh Kim Gonzalez Hohlt, Sai Shruthi Chistavajjula, Chiao Lo, Sara Pugsley, Matthew Prego, Trevor Smart, Nina Sanapareddy

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    P590: Evaluation of stop-loss and frameshift variants extending translation beyond the reference stop codon detected by carrier screening

    P590: Evaluation of stop-loss and frameshift variants extending translation beyond the reference stop codon detected by carrier screening oleh Shahida Flores, Matthew Prego, Trevor Smart, Jocelyn Wang, Julie Agapite, Sindhu Arun, Melissa Chowning, Svetlana Gramatikova, Kim Hohlt, Lili Li, Rebecca Ross, Priyanka Arya, Nina Sanapareddy

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial

    Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial oleh Jozefien Declercq, Cedric Bosteels, Karel Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Ans Vandecauter, Stefanie Vermeersch, Anja Delporte, Bénédicte Demeyere, Marnik Vuylsteke, Marianna Lalla, Trevor Smart, Laurent Detalle, René Bouw, Johannes Streffer, Thibo Degeeter, Marie Vergotte, Tanguy Guisez, Eva Van Braeckel, Catherine Van Der Straeten, Bart N. Lambrecht

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

    Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial oleh Elisabeth De Leeuw, Karel F. A. Van Damme, Jozefien Declercq, Cedric Bosteels, Bastiaan Maes, Simon J. Tavernier, Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf, Julie Deckers, Sahine Lameire, Stefaan J. Vandecasteele, Nikolaas De Neve, Ingel K. Demedts, Elke Govaerts, Christiane Knoop, Karolien Vanhove, Michel Moutschen, Wim Terryn, Pieter Depuydt, Eva Van Braeckel, Filomeen Haerynck, Tine C. J. Hendrickx, Vanessa Parrein, Marianna Lalla, Claire Brittain, Bart N. Lambrecht

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: